Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
18.02
+1.03 (+6.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
Next >
Novocure Hosts Ceremonial Groundbreaking with New Hampshire Governor Chris Sununu
April 19, 2022
From
Novocure
Via
Business Wire
Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2022 Suggesting Broad Applicability of Tumor Treating Fields
April 08, 2022
From
Novocure
Via
Business Wire
Novocure to Report First Quarter 2022 Financial Results
April 01, 2022
From
Novocure
Via
Business Wire
Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
March 24, 2022
From
Novocure
Via
Business Wire
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
March 23, 2022
From
Novocure
Via
Business Wire
Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technological Innovation
February 28, 2022
From
Novocure
Via
Business Wire
Novocure’s General Counsel Resigns After 10 Years of Service
February 24, 2022
From
Novocure
Via
Business Wire
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response
February 24, 2022
From
Novocure
Via
Business Wire
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
February 24, 2022
From
Novocure
Via
Business Wire
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
January 10, 2022
From
Novocure
Via
Business Wire
Novocure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Novocure
Via
Business Wire
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New Hampshire
December 07, 2021
From
Novocure
Via
Business Wire
Novocure Announces 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
December 06, 2021
From
Novocure
Via
Business Wire
Novocure to Participate in Two Upcoming Investor Conferences
November 23, 2021
From
Novocure
Via
Business Wire
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer
November 22, 2021
From
Novocure
Via
Business Wire
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
November 15, 2021
From
Novocure
Via
Business Wire
Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual Meeting
November 15, 2021
From
Novocure
Via
Business Wire
Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update
October 28, 2021
From
Novocure
Via
Business Wire
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal INNOVATE-3 Trial of Tumor Treating Fields in Ovarian Cancer
October 28, 2021
From
Novocure
Via
Business Wire
Novocure Announces 15 Presentations at the American Society for Radiation Oncology 2021 Annual Meeting
October 21, 2021
From
Novocure
Via
Business Wire
Novocure and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
October 04, 2021
From
Novocure
Via
Business Wire
Novocure to Report Third Quarter 2021 Financial Results
October 04, 2021
From
Novocure
Via
Business Wire
Novocure Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fields as Part of a Novel Combination for the First-line Treatment of Metastatic Pancreatic Cancer
September 14, 2021
From
Novocure
Via
Business Wire
FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer
September 09, 2021
From
Novocure
Via
Business Wire
Novocure to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
September 02, 2021
From
Novocure
Via
Business Wire
Novocure Appoints Bill Burke as Chief Human Resources Officer
September 01, 2021
From
Novocure
Via
Business Wire
Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update
July 29, 2021
From
Novocure
Via
Business Wire
Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
July 15, 2021
From
Novocure
Via
Business Wire
Novocure to Report Second Quarter 2021 Financial Results
July 08, 2021
From
Novocure
Via
Business Wire
Novocure Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Trial in Liver Cancer
July 01, 2021
From
Novocure
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.